Cel-Sci Accounts Payable

As of the most recent data (March 2026), CVM shows a accounts payable of $930M. That compares with $1.7B in the prior-year period — down 45.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CVM's accounts payable is now $930M (was $1.7B) — a 45.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cel-Sci is outperforming or lagging.

Tracking CVM's accounts payable over time shows whether Cel-Sci is scaling, shrinking, or reshaping that part of the business. The current reading is $930M That compares with $1.7B in the prior-year period — down 45.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Cel-Sci's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $930M) with ownership activity and broader fundamentals.

Cel-Sci's accounts payable is $930M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.